Surgeons regularly face problems during cancer surgery:
Marginum enables unforeseen manual control for detection of tumours:
of tumour cells
to healthy tissues
at all times
The prototype technology has been verified through testing and design iterations. Regulatory approval to proceed with clinical trials has been received. Marginum aims to conduct the market entry of its next-generation surgical technique exceptionally fast – in 2024.
Effortless, near real-time operating Marginum device monitors the surgical suction fluids’ content and analyses the intensity of tissue fluorescence.
The surgeon is informed, if any traces of tumour are present in the resected tissue with truly objective and precise feedback.
Effortless to use
Hardware-fixed interface with audio feedback from analysis
Design utilises streamlined materials & production is planned with minimal carbon footprint
Integrates seamlessly to existing workflow
Highly sensitive & specific analysis